| ADME |
Absorption, Distribution, Metabolism and Excretion |
| ANCOVA |
Analysis of Covariance |
| ANOVA |
Analysis of Variance |
| bid |
twice daily (bis in die in Latin) |
| CPT |
Clinical Pharmacology and Therapeutics (journal) |
| CTS |
Clinical Trial Simulation |
| D-R |
Dose-Response |
| D-E-R |
Dose-Exposure-Response |
| FIM (with respect to trials) |
First In Man |
| FIM (with respect to statistics) |
Fisher Information Matrix |
| IIV |
Inter-Individual Variability |
| INR |
International Normalised Ratio |
| MAD |
Multiple Ascending Dose (trial) |
| MBMA |
Model-Based Meta-Analysis |
| MCP-MOD |
Multiple Comparison Procedure - Modelling |
| MoA |
Mechanism of Action |
| MTD |
Maximum Tolerated Dose |
| N |
Sample size (=number of trial participants) |
| NHST |
Null Hypothesis Significance Testing |
| NSCLC |
Non-Small Cell Lung Cancers |
| PD |
Pharmacodynamic |
| PK |
Pharmacokinetic |
| PPD |
Price Per Dose |
| qd |
once daily (quaque die in Latin) |
| RCT |
Randomised Controlled Trial |
| RWE |
Real World Evidence |
| SAD |
Single Ascending Dose (trial) |
| SSE |
Stochastic Simulation and Estimation |
| UX |
User Experience |